Studies of Staphylococcal Infections. I. Virulence of Staphy- Lococci and Characteristics of Infections in Embryonated Eggs * WILLIAM R

Total Page:16

File Type:pdf, Size:1020Kb

Studies of Staphylococcal Infections. I. Virulence of Staphy- Lococci and Characteristics of Infections in Embryonated Eggs * WILLIAM R Journal of Clinical Investigation Vol. 43, No. 11, 1964 Studies of Staphylococcal Infections. I. Virulence of Staphy- lococci and Characteristics of Infections in Embryonated Eggs * WILLIAM R. MCCABE t (From the Research Laboratory, West Side Veterans Administration Hospital, and the Department of Medicine, Research and Educational Hospitals, University of Illinois College of Medicine, Chicago, Ill.) Many of the determinants of the pathogenesis niques still require relatively large numbers of and course of staphylococcal infections remain staphylococci to produce infection (19). Fatal imprecisely defined (1, 2) despite their increas- systemic infections have been equally difficult to ing importance (3-10). Experimental infections produce in animals and have necessitated the in- in suitable laboratory animals have been of con- jection of 107 to 109 bacteria (20-23). A few siderable assistance in clarifying the role of host strains of staphylococci have been found that are defense mechanisms and specific bacterial virulence capable of producing lethal systemic infections factors with a variety of other infectious agents. with inocula of from 102 to 103 bacteria (24) and A sensitive experimental model would be of value have excited considerable interest (25-27). The in defining the importance of these factors in virulence of these strains apparently results from staphylococcal infections, but both humans and an unusual antigenic variation (27, 28) which, the usual laboratory animals are relatively re- despite its interest, is of doubtful significance in sistant. Extremely large numbers of staphylo- human staphylococcal infection, since such strains cocci are required to produce either local or sys- have been isolated only rarely from clinical in- temic infections experimentally. Elek was un- fections (29). The insensitivity of these experi- able to produce local purulent lesions in humans mental systems has been a handicap for compari- with inocula of less than 106 staphylococci (11) son of the relative virulence of strains of staphylo- but subsequently demonstrated that the infectious cocci and evaluation of the effect of antibody and inoculum could be reduced by two to four logs other defense mechanisms in a living system. when the infection was combined with concomitant Preliminary studies of staphylococcal infections insertion of a foreign body (12). Even larger in a variety of animals indicated that embryonated numbers of staphylococci have been required to eggs were readily infected with pathogenic staphy- produce local lesions in mice (13, 14), guinea lococci (30). The present study describes the pigs (15, 16), and rabbits (17, 18). Various sensitivity of embryonated eggs to 68 strains of traumatic procedures or implantation of foreign coagulase positive Staphylococcus aureus and 36 bodies also allows the production of infection with strains of coagulase negative Staphylococcus epi- smaller numbers of bacteria in animals (14, 19), dermidis and defines some of the characteristics but despite such measures many of these tech- of this infection. Subsequent publications will de- * Submitted for publication May 4, 1964; accepted scribe the importance of individual bacterial viru- July 9, 1964. lence factors (31) and the protective effect of anti- Reported in part at the joint sessions of the American toxic and antibacterial antibody in the chick em- Society for Clinical Investigation and the American bryo (32). Federation for Clinical Research, April 28, 1963, Atlantic City, N. J. Methods This work was completed during the tenure of a Veterans Administration Clinical Investigatorship. Strains of staphylococci. Forty-two strains of coagu- t Present address: Evans Memorial Department of lase positive Staphylococcus aureus were obtained from Clinical Research, Massachusetts Memorial Hospitals, blood cultures and specimens of sputum or purulent and the Department of Medicine, Boston University exudates submitted to the routine bacteriology labora- School of Medicine, Boston University Medical Center. tory. In each instance, the patient from whom the 2146 EXPERIMENTAL STAPHYLOCOCCAL INFECTIONS IN EMBRYONATED EGGS 2147 specimen was obtained was examined to insure that the When recoveries were carried out after injection of a staphylococcus isolated was etiologically related to the large inoculum, 12-day-old eggs in which the volume of clinical infection. Additional strains were obtained allantoic fluid is stated to be 6 ml (33, 34) were used from the anterior nares and skin of a group of patients for injection. One-tenth ml samples of allantoic fluid without clinical evidence of infection who were attend- were aspirated aseptically after removal of the shell ing an outpatient clinic for the first time. Specimens over the egg sac, plated, the colonies enumerated, and were obtained only from outpatients who had not re- the numbers corrected for the 1 to 60 dilution. Re- ceived antibiotics within the past 3 months, had not covery with the smaller inoculum was performed simi- been hospitalized during this period, and whose household larly, except as much of the allantoic fluid as possible contacts had not been hospitalized recently. A third was aspirated and 4 ml of PS was injected, mixed, and group of 36 strains of coagulase negative Staphylococ- removed. The latter procedure was repeated nine times, ctus epidermidis was obtained from a variety of speci- and the pooled allantoic fluid and saline washings were mens submitted to the hospital laboratory and from the filtered through a Millipore H.A. filter (0.45 Ah). After nares and skin of outpatients. filtration, the filter was removed, placed on a blood Tube and slide coagulase determinations and mannitol agar plate, incubated for 48 hours, and the number of fermentation were performed on all isolated strains to bacterial colonies determined. insure their identification. Strains of staphylococci were In vitro growth curves. Allantoic fluid was collected maintained on tryptose phosphate (TP) agar slants aseptically from 15 eggs, pooled, and 4.9 ml dispensed at 0° C after isolation and identification until egg viru- into sterile capped tubes for determination of growth lence studies were performed the following week. curves. One-tenth ml of a 10' dilution of the organism Immediately before use, a single colony selected from to be tested was added and the allantoic fluid incubated a subculture of the original agar slant was inoculated for 18 hours. Duplicate determinations were made at into TP broth for the infectious inoculum. Several 0.1- each sampling time. Concomitant growth curves in TP ml samples of the latter were transferred to 2.5 ml of broth were performed in a similar fashion. TP broth in screw-capped vials and stored in a - 200 C In vivo growth curves. Lots of 64 10-day-old embry- deep freeze for subsequent use. onated eggs were injected with 0.1 ml of a 10' and 10' Preparation and injection of inocula. Serial tenfold dilution of coagulase positive staphylococci and 0.1 ml of dilutions of overnight TP broth cultures of staphylococci a 10' dilution of coagulase negative staphylococci. were made to provide inocula of approximately 1,000 to Four eggs from each of the three groups were sacrificed 99,999 (10' to 10') and 1 to 100 colony forming units at 4, 8, 18, and 24 hours and daily thereafter for 10 days. (cfu). The smaller inocula consisted of less than 10 Only eggs containing living embryos were sacrificed to cfu in over one-half the studies. The size of the inoculum insure that acceleration of growth and invasion of the was determined by plating 0.1 ml of 10-', 10', and 10- embryo "post-mortem" did not obscure the results. dilutions of the overnight culture on TP agar and enu- The shell over the air sac was removed; allantoic fluid merating the number of colonies after overnight incu- was aspirated aseptically and serially diluted for plate bation. Lots of 20 10-day-old fertile eggs were injected counts. The remainder of the allantoic fluid was re- intra-allantoically with 0.1 ml of 10-s and 10' dilutions moved, and 1.5% saponified cresylic acid' was added to of each strain studied, and the eggs were candied daily the shell containing the intact yolk sac, amnion, and to determine viability. A group of ten controls was in- embryo. After 10 minutes, the cresylic acid solution jected with a similar volume of sterile 0.85% saline and the yolk were removed. The amnion and embryo (PS) in each experiment. Subcultures were obtained were extracted with sterile forceps and placed in a from allantoic fluid, yolk, and embryonic blood in the sterile petri dish. The amnion was removed and the first sets of experiments and, when indicated, in sub- embryo washed in the cresylic acid solution and rinsed sequent studies to insure that maternal transmission of with sterile PS. The embryo was opened by a ventral infection or subsequent contamination had not occurred. incision, and the heart and liver were removed asepti- Eggs. Fertilized eggs were obtained from a com- cally. These were ground in a glass tube with a Teflon mercial source that did not use an antibiotic dietary tissue grinder, and 0.2 ml of the bloody supernatant supplement. Tube dilution assays for antibacterial ac- fluid was removed. Bacterial titers were determined by tivity were performed on allantoic and amniotic fluid on plating 0.1 ml of undiluted fluid and serial tenfold several occasion with negative results. Eggs were incu- dilutions of the fluid. bated for 10 davs at 370 C in a rocker incubator before infection and- then incubated upright at 38.5° C with Results 60% relative humidity for an additional 10 days after infection. Lethality of coagulase positive and coagulase Recovery of inoculum. Studies to determine the num- negative staphylococci. The 10-day fatality rates ber of cfu that could be recovered immediately after in- for 10-day-old eggs injected intra-allantoically with jection were carried out by two techniques. Eggs were inocula of two different sizes of 68 strains of co- injected as described above, allowed to stand for 15 min- utes, sealed with paraffin, shaken gently, and sacrificed.
Recommended publications
  • Reproducibility, Replicability, and Generalization in the Social, Behavioral, and Economic Sciences
    REPRODUCIBILITY, REPLICABILITY, AND GENERALIZATION IN THE SOCIAL, BEHAVIORAL, AND ECONOMIC SCIENCES Report of the Subcommittee on Replicability in Science of the SBE Advisory Committee to the National Science Foundation 13 May 2015 Presentation at SBE AC Spring Meeting by K. Bollen. Report of the Subcommittee on Replicability in Science Advisory Committee to the NSF SBE Directorate Subcommittee Members: Kenneth Bollen (University of North Carolina at Chapel Hill, Cochair) John T. Cacioppo (University of Chicago, Cochair) Robert M. Kaplan (Agency for Healthcare Research and Quality) Jon A. Krosnick (Stanford University) James L. Olds (George Mason University) Staff Assistance Heather Dean (National Science Foundation) TOPICS I. Background II. Subcommittee Report III. Definitions IV. Recommendations V. Final Comments Background • Spring, 2013 o NSF SBE Advisory Committee establishes subcommittee on how SBE can promote robust research practices • Summer & Fall 2013 o Subcommittee proposal for workshop on “Robust Research in the Social, Behavioral, and Economic Sciences.” • February 20-21, 2014 o Workshop convened o Participants drawn from variety of universities, funding agencies, scientific associations, and journals o Cover broad range of issues from extent and cause of problems to possible solutions o Details are in the appendix of the circulated report • Post-workshop period o Document & digest workshop content o Discuss and propose recommendations o Complete report Subcommittee Report • DEFINITIONS o No consensus in science on the meanings
    [Show full text]
  • The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections
    toxins Review The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections Patience Shumba 1, Srikanth Mairpady Shambat 2 and Nikolai Siemens 1,* 1 Center for Functional Genomics of Microbes, Department of Molecular Genetics and Infection Biology, University of Greifswald, D-17489 Greifswald, Germany; [email protected] 2 Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, CH-8091 Zurich, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +49-3834-420-5711 Received: 20 May 2019; Accepted: 10 June 2019; Published: 11 June 2019 Abstract: Necrotizing soft tissue infections (NSTIs) are critical clinical conditions characterized by extensive necrosis of any layer of the soft tissue and systemic toxicity. Group A streptococci (GAS) and Staphylococcus aureus are two major pathogens associated with monomicrobial NSTIs. In the tissue environment, both Gram-positive bacteria secrete a variety of molecules, including pore-forming exotoxins, superantigens, and proteases with cytolytic and immunomodulatory functions. The present review summarizes the current knowledge about streptococcal and staphylococcal toxins in NSTIs with a special focus on their contribution to disease progression, tissue pathology, and immune evasion strategies. Keywords: Streptococcus pyogenes; group A streptococcus; Staphylococcus aureus; skin infections; necrotizing soft tissue infections; pore-forming toxins; superantigens; immunomodulatory proteases; immune responses Key Contribution: Group A streptococcal and Staphylococcus aureus toxins manipulate host physiological and immunological responses to promote disease severity and progression. 1. Introduction Necrotizing soft tissue infections (NSTIs) are rare and represent a more severe rapidly progressing form of soft tissue infections that account for significant morbidity and mortality [1].
    [Show full text]
  • Severe Orbital Cellulitis Complicating Facial Malignant Staphylococcal Infection
    Open Access Austin Journal of Clinical Case Reports Case Report Severe Orbital Cellulitis Complicating Facial Malignant Staphylococcal Infection Chabbar Imane*, Serghini Louai, Ouazzani Bahia and Berraho Amina Abstract Ophthalmology B, Ibn-Sina University Hospital, Morocco Orbital cellulitis represents a major ophthalmological emergency. Malignant *Corresponding author: Imane Chabbar, staphylococcal infection of the face is a rare cause of orbital cellulitis. It is the Ophthalmology B, Ibn-Sina University Hospital, Morocco consequence of the infectious process extension to the orbital tissues with serious loco-regional and general complications. We report a case of a young diabetic Received: October 27, 2020; Accepted: November 12, child, presenting an inflammatory exophthalmos of the left eye with purulent 2020; Published: November 19, 2020 secretions with a history of manipulation of a facial boil followed by swelling of the left side of face, occurring in a febrile context. The ophthalmological examination showed preseptal and orbital cellulitis complicating malignant staphylococcal infection of the face. Orbito-cerebral CT scan showed a left orbital abscess with exophthalmos and left facial cellulitis. An urgent hospitalization and parenteral antibiotherapy was immediately started. Clinical improvement under treatment was noted without functional recovery. We emphasize the importance of early diagnosis and urgent treatment of orbital cellulitis before the stage of irreversible complications. Keywords: Orbital cellulitis, Malignant staphylococcal infection of the face, Management, Blindness Introduction cellulitis complicated by an orbital abscess with exophthalmos (Figure 2a, b), and left facial cellulitis with frontal purulent collection Malignant staphylococcal infection of the face is a serious skin (Figure 3a, b). disease. It can occur following a manipulation of a facial boil.
    [Show full text]
  • Staphylococcal Infection Information for Daycare Facilities
    Staphylococcal Infection Information for Daycare Facilities These guidelines are to help in developing a program to address managing children with methicillin-resistant Staphylococcus aureus (MRSA) infections and MRSA outbreaks specifically in the daycare setting. However, this information can be adapted to address the same problems in other settings and with almost all infectious diseases. Basic Information about MRSA The emergence of antibiotic resistant bacteria has become a significant public health concern. Due to the extensive use of antibiotics, the sharing of antibiotics, and/or the failure to complete a course of antibiotics, our current arsenal of antibiotics is becoming ineffective against common bacterial infections. Staphylococcus aureus (commonly referred to as “staph”) is a bacteria that can live on human skin of even the cleanest individuals. It can cause boils, wound infections, abscesses, cellulitis, impetigo, pneumonia, and even bloodstream infections. The Centers for Disease Control and Prevention estimate that 25-35% of children and adults in the United States have staph colonization— staph living on them, but not harming them. Staph like to live in the nose, groin, around the anus, armpits, finger tips, tracheostomy sites, wounds, and in the secretions of intubated patients. Staph spreads by direct skin-to-skin contact with an infected individual or a colonized individual or more rarely from objects contaminated by these individuals such as sheets soiled with infected wound drainage. Staph is not found in dirt or mud or carried through the air. The emergence of MRSA In the past, staph infections were easily treated with a short course of penicillin with very few complications.
    [Show full text]
  • Certification Accredited Schools List
    = Academic Clinical Research Programs Which Currently Meet Waiver Requirements for the Academy of Clinical Research Professional (Updated October 15, 2015) This list includes academic clinical research programs which, as of the above date, have been evaluated and found to meet the current waiver requirements established by the Academy of Clinical Research Professionals (Academy) Board of Trustees. Programs that meet the waiver requirements allow a candidate to waive 1,500 hours of hands-on experience performing the Essential Duties of the program to which the candidate has made application. This list is not to be considered exhaustive and is not designed to represent all the academic offerings available. Appearance on this list is not to be construed as an endorsement of its content or format by the Academy or a guarantee that a candidate will be eligible for certification. All individuals interested in enrolling in a program of study should evaluate any program on the basis of his or her personal needs. (* - programs marked with an asterisk MAY be accepted but acceptance will be dependent on the complete listing of courses completed) Individuals seeking additional information about each program should contact the institution directly. Academic Institution Program Name ( Click Title for Web Navigation) Academy of Applied Pharmaceutical Sciences Clinical Research Diploma Program American University of Health Sciences Master of Science in Clinical Research Anoka-Ramsey Community College Clinical Research Professional - Certificate Graduate
    [Show full text]
  • Placebo-Controlled Trials of New Drugs: Ethical Considerations
    Reviews/Commentaries/Position Statements COMMENTARY Placebo-Controlled Trials of New Drugs: Ethical Considerations DAVID ORENTLICHER, MD, JD als, placebo controls are not appropriate when patients’ health would be placed at significant risk (8–10). A placebo- controlled study for a new hair- uch controversy exists regarding sufficiently more effective than placebo to thickening agent could be justified; a the ethics of placebo-controlled justify its use. Finally, not all established placebo-controlled study for patients M trials in which an experimental therapies have been shown to be superior with moderate or severe hypertension therapy will compete with an already es- to placebo. If newer drugs are compared would not be acceptable (11). Similarly, if tablished treatment (or treatments). In with the unproven existing therapies, an illness causes problems when it goes such cases, argue critics, patients in the then patients may continue to receive untreated for a long period of time, a 52- control arm of the study should receive an drugs that are harmful without being week study with a placebo control is accepted therapy rather than a placebo. helpful. much more difficult to justify than a By using an active and effective drug, the Moreover, say proponents of placebo 6-week study (12). control patients would not be placed at controls, patients can be protected from When David S.H. Bell (13) explains risk for deterioration of their disease, and harm by “escape” criteria, which call for why placebo controls are unacceptable the study would generate more meaning- withdrawal from the trial if the patient for new drugs to treat type 2 diabetes, he ful results for physicians.
    [Show full text]
  • Generating Real-World Evidence by Strengthening Real-World Data Sources
    Generating Real-World Evidence by Strengthening Real-World Data Sources Using “real-world evidence” to bring new “Every day, health care professionals are updating patients’ treatments to patients as part of the 21st electronic health records with data on clinical outcomes Century Cures Act (the “Cures Act”) is a key resulting from medical interventions used in routine clinical priority for the Department of Health and practice. As our experience with new medical products Human Services (HHS). Specifically, the Cures expands, our knowledge about how to best maximize their Act places focus on the use of real-world data benefits and minimize potential risks sharpens with each data to support regulatory decision-making, including point we gather. Every clinical use of a product produces data the approval of new indications for existing that can help better inform us about its safety and efficacy.” drugs in order to make drug development faster jacqueline corrigan-curay, md, jd and more efficient. As such, the Cures Act director of the office of medical policy in fda’s center for drug evaluation and research has tasked the Food and Drug Administration (FDA) to develop a framework and guidance for evaluating real-world evidence in the context of drug regulation.1 Under the FDA’s framework, real-world evidence (RWE) is generated by different study designs or analyses, including but not limited to, randomized trials like large simple trials, pragmatic trials, and observational studies. RWE is the clinical evidence about the use, potential benefits, and potential risks of a medical product based on an analysis of real-world data (RWD).
    [Show full text]
  • Evaluating Alternative Hypotheses to Explain the Downward Trend in the Indices of the COVID-19 Pandemic Death Rate
    Evaluating alternative hypotheses to explain the downward trend in the indices of the COVID-19 pandemic death rate Sonali Shinde1, Pratima Ranade1 and Milind Watve2 1 Department of Biodiversity, Abasaheb Garware College, Pune, Pune, Maharashtra, India 2 Independent Researcher, Pune, Maharashtra, India ABSTRACT Background: In the ongoing Covid-19 pandemic, in the global data on the case fatality ratio (CFR) and other indices reflecting death rate, there is a consistent downward trend from mid-April to mid-November. The downward trend can be an illusion caused by biases and limitations of data or it could faithfully reflect a declining death rate. A variety of explanations for this trend are possible, but a systematic analysis of the testable predictions of the alternative hypotheses has not yet been attempted. Methodology: We state six testable alternative hypotheses, analyze their testable predictions using public domain data and evaluate their relative contributions to the downward trend. Results: We show that a decline in the death rate is real; changing age structure of the infected population and evolution of the virus towards reduced virulence are the most supported hypotheses and together contribute to major part of the trend. The testable predictions from other explanations including altered testing efficiency, time lag, improved treatment protocols and herd immunity are not consistently supported, or do not appear to make a major contribution to this trend although they may influence some other patterns of the epidemic. Conclusion: The fatality of the infection showed a robust declining time trend between mid April to mid November. Changing age class of the infected and Submitted 7 December 2020 Accepted 3 March 2021 decreasing virulence of the pathogen were found to be the strongest contributors to Published 20 April 2021 the trend.
    [Show full text]
  • Metabolic Sensor Governing Bacterial Virulence in Staphylococcus Aureus
    Metabolic sensor governing bacterial virulence in PNAS PLUS Staphylococcus aureus Yue Dinga, Xing Liub, Feifei Chena, Hongxia Dia, Bin Xua, Lu Zhouc, Xin Dengd,e, Min Wuf, Cai-Guang Yangb,1, and Lefu Lana,1 aDepartment of Molecular Pharmacology and bChinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; cDepartment of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China; dDepartment of Chemistry and eInstitute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637; and fDepartment of Basic Sciences University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58203 Edited by Richard P. Novick, New York University School of Medicine, New York, NY, and approved October 14, 2014 (received for review June 13, 2014) An effective metabolism is essential to all living organisms, in- To survive and replicate efficiently in the host, S. aureus has cluding the important human pathogen Staphylococcus aureus.To developed exquisite mechanisms for scavenging nutrients and establish successful infection, S. aureus must scavenge nutrients adjusting its metabolism to maintain growth while also coping with and coordinate its metabolism for proliferation. Meanwhile, it also stress (6, 11). On the other hand, S. aureus produces a wide array must produce an array of virulence factors to interfere with host of virulence factors to evade host immune defenses and to derive defenses. However, the ways in which S. aureus ties its metabolic nutrition either parasitically or destructively from the host during state to its virulence regulation remain largely unknown. Here we infections (6).
    [Show full text]
  • Principles of Validation of Diagnostic Assays for Infectious Diseases1
    PRINCIPLES OF VALIDATION OF DIAGNOSTIC ASSAYS FOR INFECTIOUS DISEASES1 R. H. JACOBSON, New York State College of Veterinary Medicine, Cornell University, Ithaca, New York, USA Abstract PRINCIPLES OF VALIDATION OF DIAGNOSTIC ASSAYS FOR INFECTIOUS DISEASES. Assay validation requires a series of inter-related processes. Assay validation is an experimental process: reagents and protocols are optimized by experimentation to detect the analyte with accuracy and precision. Assay validation is a relative process: its diagnostic sensitivity and diagnostic specificity are calculated relative to test results obtained from reference animal populations of known infection/exposure status. Assay validation is a conditional process: classification of animals in the target population as infected or uninfected is conditional upon how well the reference animal population used to validate the assay represents the target population; accurate predictions of the infection status of animals from test results (PV+ and PV−) are conditional upon the estimated prevalence of disease/infection in the target population. Assay validation is an incremental process: confidence in the validity of an assay increases over time when use confirms that it is robust as demonstrated by accurate and precise results; the assay may also achieve increasing levels of validity as it is upgraded and extended by adding reference populations of known infection status. Assay validation is a continuous process: the assay remains valid only insofar as it continues to provide accurate and precise results as proven through statistical verification. Therefore, the work required for validation of diagnostic assays for infectious diseases does not end with a time-limited series of experiments based on a few reference samples rather, to assure valid test results from an assay requires constant vigilance and maintenance of the assay, along with reassessment of its performance characteristics for each unique population of animals to which it is applied.
    [Show full text]
  • New NIH Guidelines to Improve Experimental Rigor and Reproducibility
    New NIH guidelines to improve Experimental Rigor and Reproducibility Oswald Steward Professor, Department of Anatomy & Neurobiology Senior Associate Dean for Research University of California School of Medicine What I’ll tell you 1) Background: Increasing reports of failures to replicate 2) Previous actions by NIH to enhance rigor 3) New requirements for grants submitted after January 2016 4) What NIH will be looking for in new required sections 5) Some suggested best practices to meet new standards for scientific rigor • The Problem: Numerous recent reports of findings that can’t be replicated. Failure to replicate key results from preclinical cancer studies: 1) Prinz et al. (2011) Believe it or not: How much can we rely on published data on potential drug targets? Nature Reviews Drug Discovery. Inconsistencies were found in 2/3 studies 2) Begley and Ellis (2012) Raise standards for preclinical cancer research. Nature. Only 6/53 “landmark” papers replicated 3) Begley (2013) Six red flags for suspect work. Nature. -Were experiments performed blinded? -Were basic experiments repeated? -Were all the results presented? -Were there positive and negative controls? -Were reagents validated? -Were statistical tests appropriate? • In ALS field, Scott et al., (2008) re-assessed 70 drugs that had been reported to increase lifespan in an animal model of ALS (SOD1-G93A knockout mice). • 221 separate studies were carried out over a five year period that involved over 18,000 mice. • Some drugs were already in clinical trials. • Outcome: There was no statistically significant positive effect for any of the 70 compounds tested. • Conclusion: Previously published effects were measurements of noise in the distribution of survival means as opposed to an actual drug effect.
    [Show full text]
  • Virulence During Newcastle Disease Viruses Cross Species Adaptation
    viruses Review Virulence during Newcastle Disease Viruses Cross Species Adaptation Claudio L. Afonso Base2bio, LLC, Oshkosh, WI 54905, USA; [email protected]; Tel.: +1-800-817-7160 Abstract: The hypothesis that host adaptation in virulent Newcastle disease viruses (NDV) has been accompanied by virulence modulation is reviewed here. Historical records, experimental data, and phylogenetic analyses from available GenBank sequences suggest that currently circulating NDVs emerged in the 1920–19400s from low virulence viruses by mutation at the fusion protein cleavage site. These viruses later gave rise to multiple virulent genotypes by modulating virulence in opposite directions. Phylogenetic and pathotyping studies demonstrate that older virulent NDVs further evolved into chicken-adapted genotypes by increasing virulence (velogenic-viscerotropic pathotypes with intracerebral pathogenicity indexes [ICPIs] of 1.6 to 2), or into cormorant-adapted NDVs by moderating virulence (velogenic–neurotropic pathotypes with ICPIs of 1.4 to 1.6), or into pigeon-adapted viruses by further attenuating virulence (mesogenic pathotypes with ICPIs of 0.9 to 1.4). Pathogenesis and transmission experiments on adult chickens demonstrate that chicken-adapted velogenic-viscerotropic viruses are more capable of causing disease than older velogenic-neurotropic viruses. Currently circulating velogenic–viscerotropic viruses are also more capable of replicating and of being transmitted in naïve chickens than viruses from cormorants and pigeons. These evolutionary virulence changes are consistent with theories that predict that virulence may evolve in many directions in order to achieve maximum fitness, as determined by genetic and ecologic constraints. Keywords: NDV; evolution; virulence; host adaptation Citation: Afonso, C.L. Virulence during Newcastle Disease Viruses Cross Species Adaptation.
    [Show full text]